Skip to main content

ProVerum Medical

ProVerum Medical develops minimally invasive devices utilizing a proprietary technology to treat benign prostatic hyperplasia, a condition that causes urinary obstruction in men. Their approach aims to reduce patient recovery time and minimize complications associated with traditional surgical methods.

Traction 10/10
Dublin, Ireland · HQ
Founded 2014261K+ followers
  • Healthcare Technology
  • Medical Devices
Updated 23 months ago

Funding

Raised to date

$43.3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

Susan O'Coinne

Chief Financial Officer

Product

Problem

Benign prostatic hyperplasia (BPH) causes urinary obstruction in men, leading to discomfort and reduced quality of life. Traditional surgical treatments for BPH can be invasive, resulting in extended recovery times and potential complications.

Solution

ProVerum Medical is developing minimally invasive devices that utilize a proprietary technology to treat BPH. Their approach aims to alleviate urinary obstruction while minimizing the trauma associated with traditional surgical methods. By reducing invasiveness, ProVerum seeks to shorten patient recovery time and decrease the risk of complications. The company's focus is on improving the patient experience and outcomes in BPH treatment through innovative device design.

Target Audience

The primary target audience is men experiencing urinary obstruction due to benign prostatic hyperplasia.

Features

  • Minimally invasive device for BPH treatment
  • Proprietary technology to reduce trauma during the procedure
  • Designed to alleviate urinary obstruction
  • Aims to shorten patient recovery time compared to traditional surgery
  • Focus on minimizing complications associated with BPH treatment
This profile is AI-generated and may contain inaccuracies.